Strategic Advocates’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-195
Closed -$22.2K 355
2025
Q4
$22.2K Sell
195
-1,250
-87% -$152K 0.01% 279
2025
Q3
$192K Hold
1,445
0.05% 128
2025
Q2
$206K Hold
1,445
0.06% 123
2025
Q1
$221K Buy
1,445
+8
+0.6% +$1.26K 0.08% 100
2024
Q4
$215K Sell
1,437
-539
-27% -$84.5K 0.07% 103
2024
Q3
$324K Sell
1,976
-738
-27% -$109K 0.12% 91
2024
Q2
$376K Sell
2,714
-2,300
-46% -$317K 0.15% 83
2024
Q1
$692K Sell
5,014
-339
-6% -$40.7K 0.27% 59
2023
Q4
$561K Buy
5,353
+344
+7% +$31.8K 0.24% 80
2023
Q3
$474K Buy
+5,009
New +$511K 0.22% 87

Other funds holding DVA

Strategic Advocates's DVA Position: Q1 2026 in Review

Strategic Advocates sold out of DaVita (DVA) in Q1 2026, closing a stake of 195 shares — an estimated $22.2K sold.

Strategic Advocates first reported a position in DVA in Q3 2023 and held it in 10 quarters. The position peaked at $692K in Q1 2024. 582 funds tracked by Wall St. Rank hold DVA as of Q1 2026.

  • Strategic Advocates reported no remaining DaVita position as of Q1 2026 after selling out during the quarter.
  • Strategic Advocates sold 195 DaVita shares in Q1 2026, an estimated $22.2K.
  • Strategic Advocates first reported a position in DaVita in Q3 2023 and held it in 10 quarters.
  • Strategic Advocates's DaVita position peaked at $692K in Q1 2024.
  • 582 funds tracked by Wall St. Rank held DaVita as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.